Logo
csv. check, some, votes

Objection pursuant to Rule 112(2) and (3) on the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin

Reference: B9-0162/2021

Date: 10.03.2021

Previous
Next

Renew Europe (Renew)

97 Members

Group Voting Result
Total: 97 MEPs
69 For
28 Against
0 Abstention
0 Did not vote
69 For
28 Against
0 Abstention
0 Did not vote
Group Members
← Back to Vote